Enanta Pharmaceuticals
ENTA
ENTA
126 hedge funds and large institutions have $396M invested in Enanta Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 46 increasing their positions, 48 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
126
Holders Change
-23
Holders Change %
-15.44%
% of All Funds
3.14%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.05%
New
16
Increased
46
Reduced
48
Closed
32
Calls
$412K
Puts
$1.79M
Net Calls
-$1.38M
Net Calls Change
-$1.87M
Top Buyers
| 1 |
1
BlackRock
New York
|
$70.7M |
| 2 |
2
First Manhattan
New York
|
$27.1M |
| 3 |
3
Millennium Management
New York
|
$13.6M |
| 4 |
GTC
4
Ghost Tree Capital
New York
|
$9.24M |
| 5 |
5
Dimensional Fund Advisors
Austin,
Texas
|
$12.7M |
